Additionally, PDE5 inhibitors display an insulin-like effect on insulin-sensitizing cells such as skeletal muscle cells, adipocytes, and endothelial cells, leading to the attenuation of insulin resistance [10–13]. Here, PDE5A is linked to Insulin resistance.